SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision

What are the optimal timing windows for TREM2 inhibition vs activation in Alzheimer's disease progression?

PARTIALLY ADDRESSED

The debate proposed temporal TREM2 modulation but couldn't define when to switch from inhibition to activation phases. This fundamental timing question remains unresolved despite being critical for therapeutic success. Source: Debate session sess_SDA-2026-04-10-trem2-ad (Analysis: trem2-ad)

Priority: 0.90 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What are the optimal timing windows for TREM2 inhibition vs activation in Alzheimer's disease progression? is a 0.9 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What are the optimal timing windows for TREM2 inhibition vs activation in Alzheimer's disease progression? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (15)

TREM2→NeuroinflammationTREM2→AlsGENES→AlzheimerAlzheimer→EpigeneticTNF→Alzheimer
▸ Show 10 more

associated with (9)

Alzheimer→AutophagyAlzheimer→Lipid MetabolismAlzheimer→Amyotrophic Lateral SclerosisDiabetes→AlzheimerMTOR→Alzheimer
▸ Show 4 more

biomarker for (2)

GFAP→AlzheimerNFL→Alzheimer

data in (3)

TREM2→benchmark_ot_ad_answer_key:TREM2benchmark_ot_ad_answer_key:TREM2→TREM2ad_genetic_risk_loci:TREM2→TREM2

expressed in (3)

APOE4→AlzheimerTREM2→MICROGLIATREM2→Alzheimer

regulates (6)

Alzheimer→Lipid MetabolismGENES→AlzheimerAKT→AlzheimerAPOE→AlzheimerTREM2→Alzheimer
▸ Show 1 more

relates to (2)

h-immunity-c3bc272f→TREM2h-immunity-c64967ab→TREM2

therapeutic target (10)

Alzheimer→Lipid MetabolismAlzheimer→Blood-Brain BarrierAlzheimer→Immune ResponseDNA→AlzheimerOVERVIEW→Alzheimer
▸ Show 5 more
🕑 Activity Feed
✏ update on knowledge_gap by max_gmail 2026-04-28T00:18
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps